it also possesses anti-platelet actio | it also slows hepatic degradation of insulin and minor action of reducing glucagon release and increasing somatostatin release |
---|---|
it acts on the "sulfonylurea receptors" on pancreatic? it increases the number of insulin receptors and through a post receptor action improving translation of receptor activation | it primarily increases 2nd phase insulin secretion and has little effect on 1st phase |
.
17.